Biotech Analyst Hsieh discusses recent initiation of coverage for Lantheus (LNTH) and RayzeBio (RYZB) two radiopharmaceutical companies on an Analyst/Industry conference call to be held on October 12 at 12:30 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LNTH:
- Lantheus program validated by Point Biopharma buyout, says Mizuho
- Eli Lilly deal for Point puts radiopharma names in spotlight
- JMP Securities remains bullish on Lantheus after Lilly’s acquisition of Point Biopharma
- Point Biopharma deal reads positively to radiopharma names, says B. Riley
- Lantheus jumps after Eli Lilly agrees to buy Point Biopharma